- Home
- SYRE vs RXO Comparison
SYRE vs RXO Comparison
Compare SYRE & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | RXO |
|---|---|---|
| Founded | 2013 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | RXO |
|---|---|---|
| Price | $33.03 | $12.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 15 |
| Target Price | ★ $56.50 | $16.25 |
| AVG Volume (30 Days) | 925.8K | ★ 2.0M |
| Earning Date | 11-04-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,940,000,000.00 |
| Revenue This Year | N/A | $28.02 |
| Revenue Next Year | N/A | $3.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 53.85 |
| 52 Week Low | $10.91 | $10.43 |
| 52 Week High | $35.31 | $26.92 |
Technical Indicators
Market Signals| Indicator | SYRE | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 62.10 | 39.55 |
| Support Level | $32.50 | $13.75 |
| Resistance Level | $34.84 | $16.00 |
| Average True Range (ATR) | 1.48 | 0.70 |
| MACD | -0.37 | -0.16 |
| Stochastic Oscillator | 25.90 | 4.66 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.